129 related articles for article (PubMed ID: 14634801)
21. Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival.
Ochs AM; Wong L; Kakani V; Neerukonda S; Gorske J; Rao A; Riggs M; Ward H; Keville L
Clin Colorectal Cancer; 2004 Nov; 4(4):262-7. PubMed ID: 15555209
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
Khan AJ; King BL; Smith BD; Smith GL; DiGiovanna MP; Carter D; Haffty BG
Clin Cancer Res; 2002 Feb; 8(2):540-8. PubMed ID: 11839675
[TBL] [Abstract][Full Text] [Related]
23. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
[TBL] [Abstract][Full Text] [Related]
24. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
[TBL] [Abstract][Full Text] [Related]
25. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions.
Stefanou D; Batistatou A; Zioga A; Arkoumani E; Papachristou DJ; Agnantis NJ
Int J Surg Pathol; 2004 Apr; 12(2):133-8. PubMed ID: 15173918
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of HER-2/neu expression in colon cancer].
Park DI; Oh SJ; Park SH; Yun JW; Kim HJ; Cho YK; Sung IK; Sohn CI; Jeon WK; Kim BI; Cho EY; Kim EJ; Chae SW; Sohn JH; Kim JJ
Korean J Gastroenterol; 2004 Sep; 44(3):147-52. PubMed ID: 15385723
[TBL] [Abstract][Full Text] [Related]
28. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
29. Case of rectal malignant melanoma showing immunohistochemical variability in a tumor.
Seya T; Tanaka N; Shinji S; Shinji E; Yokoi K; Horiba K; Kanazawa Y; Yamada T; Oaki Y; Tajiri T
J Nippon Med Sch; 2007 Oct; 74(5):377-81. PubMed ID: 17965534
[TBL] [Abstract][Full Text] [Related]
30. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
Menendez JA; Vellon L; Oza BP; Lupu R
J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
[TBL] [Abstract][Full Text] [Related]
31. Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors.
Forseen SE; Potti A; Koka V; Koch M; Fraiman G; Levitt R
Anticancer Res; 2002; 22(3):1599-602. PubMed ID: 12168843
[TBL] [Abstract][Full Text] [Related]
32. Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma.
Potti A; Ganti AK; Tendulkar K; Sholes K; Chitajallu S; Koch M; Kargas S
J Cancer Res Clin Oncol; 2004 Jan; 130(1):52-6. PubMed ID: 14600832
[TBL] [Abstract][Full Text] [Related]
33. [Expression of CD117, MITF and NAT10 and their prognostic values in sinonasal mucosal melanoma].
Han F; Liu HQ; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):931-935. PubMed ID: 30522174
[No Abstract] [Full Text] [Related]
34. Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis.
Boone J; van Hillegersberg R; Offerhaus GJ; van Diest PJ; Borel Rinkes IH; Ten Kate FJ
Dis Esophagus; 2009; 22(6):496-504. PubMed ID: 19302210
[TBL] [Abstract][Full Text] [Related]
35. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
36. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
[TBL] [Abstract][Full Text] [Related]
37. CD117 (c-kit) expression in human hepatocellular carcinoma.
Becker G; Schmitt-Graeff A; Ertelt V; Blum HE; Allgaier HP
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):204-8. PubMed ID: 17359908
[TBL] [Abstract][Full Text] [Related]
38. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
39. Primary Sinonasal Malignant Melanoma: Effect of Clinical and Histopathologic Prognostic Factors on Survival.
Göde S; Turhal G; Tarhan C; Yaman B; Kandiloğlu G; Öztürk K; Kaya İ; Midilli R; Karcı B
Balkan Med J; 2017 May; 34(3):255-262. PubMed ID: 28443572
[TBL] [Abstract][Full Text] [Related]
40. Role of immunohistochemical identification of Her-2/neu and detection of variability in overexpression in pancreatic carcinoma.
Koka V; Potti A; Koch M; Fraiman G; Mehdi S; Levitt R
Anticancer Res; 2002; 22(3):1593-7. PubMed ID: 12168842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
